Literature DB >> 6271045

Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells.

M J Browne.   

Abstract

Actinomycin D inhibited the yield of influenza virus hemagglutinin from MDCK cells infected at high multiplicity, but had little effect on the yield of parainfluenza virus hemagglutinin. In similar hemagglutinin yield experiments, ribavirin was only slightly more active (threefold) against influenza virus than against parainfluenza virus replication. In plaque inhibition experiments, ribavirin depressed influenza virus plaque formation by 50% at a concentration of approximately 3 micrograms/ml, whereas the corresponding figure for parainfluenza viruses was threefold higher. The concentration of ribavirin demonstrating anti-influenza activity was indistinguishable for that inhibiting host cell growth. It is concluded that, unlike actinomycin D, ribavirin is unlikely to have a major effect on the provision of host cell 5-germinal methylated cap structures and the subsequent priming of influenza messenger ribonucleic acid synthesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271045      PMCID: PMC181511          DOI: 10.1128/AAC.19.5.712

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  THE EFFECTS OF ACTINOMYCIN D AND ULTRAVIOLET IRRADIATION ON THE PRODUCTION OF FOWL PLAGUE VIRUS.

Authors:  R D BARRY
Journal:  Virology       Date:  1964-12       Impact factor: 3.616

2.  Fluoroimidazoles as antiviral agents and inhibitors of polynucleotide biosynthesis.

Authors:  E De Cercq; M Luczak
Journal:  Life Sci       Date:  1975-07-15       Impact factor: 5.037

3.  In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections.

Authors:  R W Sidwell; G P Khare; L B Allen; J G Huffman; J T Witkowski; L N Simon; R K Robins
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

4.  Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.

Authors:  B Eriksson; E Helgstrand; N G Johansson; A Larsson; A Misiorny; J O Norén; L Philipson; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

5.  An evaluation of a new antiviral agent "virazole" against influenza virus infections.

Authors:  T Suganuma; N Ishida
Journal:  Tohoku J Exp Med       Date:  1973-08       Impact factor: 1.848

6.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

7.  Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin).

Authors:  J S Oxford
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

8.  Inhibition of influenza RNA synthesis by virazole (ribavirin).

Authors:  C Scholtissek
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.

Authors:  J H Huffman; R W Sidwell; G P Khare; J T Witkowski; L B Allen; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

10.  In vitro effect of virazole against influenza viruses.

Authors:  Y Togo
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191

View more
  7 in total

1.  Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.

Authors:  J J Kirsi; J A North; P A McKernan; B K Murray; P G Canonico; J W Huggins; P C Srivastava; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

Review 2.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

3.  Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.

Authors:  M J Browne; M Y Moss; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

4.  Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.

Authors:  J J Kirsi; P A McKernan; N J Burns; J A North; B K Murray; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

Review 5.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935

Review 6.  Antiviral therapy for respiratory tract infections.

Authors:  Samson S Y Wong; Kwok-Yung Yuen
Journal:  Respirology       Date:  2008-11       Impact factor: 6.424

Review 7.  Treatment of respiratory virus infections.

Authors:  Yacine Abed; Guy Boivin
Journal:  Antiviral Res       Date:  2006-02-14       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.